Cargando…
Association between Proton Pump Inhibitor Use and the Risk of Female Cancers: A Nested Case-Control Study of 23 Million Individuals
SIMPLE SUMMARY: The safety of long-term PPI use has increasingly raised concerns. We conducted a case-control study to explore the associations of PPI use with female cancer risks in specific age groups. Overall, PPI use was significantly associated with decreased risks of breast, cervical, endometr...
Autores principales: | Nguyen, Nhi Thi Hong, Huang, Chih-Wei, Wang, Ching-Huan, Lin, Ming-Chin, Hsu, Jason C., Hsu, Min-Huei, Iqbal, Usman, Nguyen, Phung-Anh, Yang, Hsuan-Chia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776228/ https://www.ncbi.nlm.nih.gov/pubmed/36551573 http://dx.doi.org/10.3390/cancers14246083 |
Ejemplares similares
-
Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study
por: Nguyen, Nhi Thi Hong, et al.
Publicado: (2023) -
Chemopreventive Effects of Concomitant or Individual Use of Statins, Aspirin, Metformin, and Angiotensin Drugs: A Study Using Claims Data of 23 Million Individuals
por: Wang, Ching-Huan, et al.
Publicado: (2022) -
Is Long-term Use of Benzodiazepine a Risk for Cancer?
por: Iqbal, Usman, et al.
Publicado: (2015) -
Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study
por: Peng, Yen-Chun, et al.
Publicado: (2018) -
Proton Pump Inhibitor Use is Associated With Risk of Pancreatic
Cancer: A Nested Case–Control Study
por: Peng, Yen-Chun, et al.
Publicado: (2018)